BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Week In Review: A Late Summer Bounce For Biotech


9/5/2006 6:53:16 PM

September 3, 2006 – Biotech continued to bounce higher from its mid-July lows during the past week. In quiet pre-holiday trading, the Centient Biotech 200™ moved up 86 points to 3761.84, a rise of 2.34%. Breadth continued to outperform the rising index, a strong confirming signal of the recent six-week advance. The IPO market, however, remains in its late-summer doldrums. CytRx was the leading percentage gainer of the week, gaining on news of a $24.5 million cash infusion; Prana continued its run toward a 52-week high on no news; Xenoport posted a strong 23.5% increase without releasing more data on its diverse drug portfolio; SuperGen traded up on speculation that its partner MGI Pharma might take it over; Corcept continued to fall in the week following the failure of psych drug Corlux in a Phase III trial; and Critical Therapeutics gave back gains that followed positive data from zileuton IV, an asthma drug. More details...

Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES